Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
CYRX

CYRX - CryoPort Inc Stock Price, Fair Value and News

7.89USD-1.81 (-18.66%)Market Closed

Market Summary

CYRX
USD7.89-1.81
Market Closed
-18.66%

CYRX Alerts

  • 1 major insider sales recently.
  • Big fall in Revenue (Y/Y)
  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

CYRX Stock Price

View Fullscreen

CYRX RSI Chart

CYRX Valuation

Market Cap

388.6M

Price/Earnings (Trailing)

-3.44

Price/Sales (Trailing)

1.73

EV/EBITDA

-9.08

Price/Free Cashflow

-9.71

CYRX Price/Sales (Trailing)

CYRX Profitability

Operating Margin

41.79%

EBT Margin

-50.19%

Return on Equity

-23.91%

Return on Assets

-11.98%

Free Cashflow Yield

-10.3%

CYRX Fundamentals

CYRX Revenue

Revenue (TTM)

225.0M

Rev. Growth (Yr)

-13.09%

Rev. Growth (Qtr)

-4.66%

CYRX Earnings

Earnings (TTM)

-112.9M

Earnings Growth (Yr)

-238.98%

Earnings Growth (Qtr)

69.71%

Breaking Down CYRX Revenue

Last 7 days

-19.4%

Last 30 days

-28.5%

Last 90 days

-54.5%

Trailing 12 Months

-56.4%

How does CYRX drawdown profile look like?

CYRX Financial Health

Current Ratio

10.73

Debt/Equity

0.8

Debt/Cashflow

-0.02

CYRX Investor Care

Shares Dilution (1Y)

8.15%

Diluted EPS (TTM)

-2.48

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024225.0M000
2023247.8M240.7M236.4M233.3M
2022225.5M231.4M234.3M237.3M
2021122.2M169.0M214.5M222.6M
202037.1M38.0M39.6M78.7M
201922.3M26.1M30.4M33.9M
201813.3M15.0M17.3M19.6M
20178.8M9.8M10.9M12.0M
20165.9M6.4M6.9M7.7M
20154.3M4.8M5.4M5.9M
20142.7M3.1M3.4M3.6M
20131.1M1.4M1.7M2.2M
2012555.6K622.9K746.2K908.9K
2011475.5K447.8K434.1K478.8K
2010118.0K207.3K296.7K386.1K
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of CryoPort Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 17, 2024
hariri robert j
acquired
-
-
12,845
-
May 17, 2024
hancock daniel m
acquired
-
-
12,845
-
May 17, 2024
mandalam ramkumar
acquired
-
-
12,845
-
May 17, 2024
baddour linda
acquired
-
-
12,845
-
May 17, 2024
berman richard j
acquired
-
-
12,845
-
May 15, 2024
berman richard j
sold
-108,693
13.4106
-8,105
-
May 14, 2024
zecchini edward j
sold
-46,042
13.3727
-3,443
chief digital and tech officer
Mar 25, 2024
shelton jerrell
sold
-46,153
17.5423
-2,631
chief executive officer

1–10 of 50

Which funds bought or sold CYRX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
new
-
194
194
-%
May 16, 2024
COMERICA BANK
added
73.01
30,422
61,594
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-4.47
71,846
856,291
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-32.39
-125,096
424,907
-%
May 15, 2024
JANUS HENDERSON GROUP PLC
reduced
-1.08
1,554,120
13,483,300
0.01%
May 15, 2024
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
unchanged
-
14,000
108,000
-%
May 15, 2024
Blackstone Inc.
unchanged
-
1,002,000
8,025,110
0.03%
May 15, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
3.05
129,000
859,000
-%
May 15, 2024
GOLDMAN SACHS GROUP INC
reduced
-27.48
-495,106
2,394,740
-%
May 15, 2024
B. Metzler seel. Sohn & Co. AG
unchanged
-
88,864
711,717
0.01%

1–10 of 39

Are Funds Buying or Selling CYRX?

Are funds buying CYRX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CYRX
No. of Funds

Unveiling CryoPort Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
cadian capital management, lp
7.1%
34,640
SC 13G
Feb 14, 2024
brown capital management llc
13.79%
6,754,317
SC 13G/A
Feb 14, 2024
alger associates inc
4.1%
1,989,100
SC 13G/A
Feb 13, 2024
vanguard group inc
7.47%
3,657,661
SC 13G/A
Feb 08, 2024
morgan stanley
8.5%
4,141,522
SC 13G
Jan 26, 2024
blackrock inc.
7.3%
3,568,644
SC 13G/A
Feb 14, 2023
brown capital management llc
14.20%
6,959,207
SC 13G/A
Feb 14, 2023
alger associates inc
5.6%
2,720,035
SC 13G/A
Feb 09, 2023
vanguard group inc
7.21%
3,535,073
SC 13G/A
Feb 08, 2023
invesco ltd.
1.8%
904,984
SC 13G/A

Recent SEC filings of CryoPort Inc

View All Filings
Date Filed Form Type Document
Jun 14, 2024
S-8
Employee Benefits Plan
May 30, 2024
SD
SD
May 22, 2024
8-K
Current Report
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 16, 2024
4
Insider Trading
May 15, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to CryoPort Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
63.2B
87.5B
3.65% 10.45%
14.37
0.72
-5.51% 46.89%
44.9B
16.6B
-5.25% 24.09%
24.57
2.7
6.06% 9.62%
37.2B
7.4B
-1.48% 14.33%
32.17
5.04
3.46% 4.06%
17.9B
8.9B
7.66% 10.96%
25.77
2.01
-40.57% -43.75%
16.3B
12.5B
0.18% -9.86%
24.78
1.3
-13.82% -28.77%
10.4B
17.4B
2.01% -2.20%
34.17
0.6
-22.65% -61.39%
MID-CAP
7.9B
7.3B
2.49% -9.46%
71.68
1.08
1.23% -83.48%
7.4B
4.5B
-2.55% 39.20%
19.66
1.64
3.72% 12.24%
5.9B
9.3B
-4.44% 16.27%
14.21
0.64
9.73% -2.71%
2.5B
4.4B
1.24% 25.95%
20.68
0.58
-10.46% -59.38%
SMALL-CAP
818.1M
3.1B
-9.57% 5.35%
16.97
0.27
-22.33% -73.30%
627.8M
1.1B
1.20% 15.17%
14.75
0.56
-6.43% -58.73%
391.3M
1.6B
-0.12% 0.61%
-22.11
0.25
-11.50% -135.26%
388.6M
225.0M
-28.53% -56.43%
-3.44
1.73
-9.19% -258.40%
66.8M
220.4M
-6.70% -11.05%
-6.14
0.3
16.77% -270.60%

CryoPort Inc News

Latest updates
Defense World17 Jun 202411:35 am
Simply Wall St05 Jun 202407:00 am
Yahoo Finance08 May 202407:00 am
InvestorPlace11 months ago
The Motley Fool11 months ago

CryoPort Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
Revenue-4.7%54,592,00057,260,00056,157,00057,021,00062,817,00060,358,00060,464,00064,153,00052,302,00054,371,00056,440,00056,693,00056,191,00053,284,00048,361,00011,172,0009,389,0009,774,0009,242,0009,583,0008,464,000
Cost Of Revenue-3.5%32,817,00033,999,00031,891,00032,288,00035,745,00034,081,00034,047,00035,315,00029,961,000-33,327,50033,180,00030,789,00028,734,00028,467,0005,117,0004,262,0004,516,0004,309,5134,956,2774,125,199
Gross Profit-6.4%21,775,00023,261,00024,266,00024,733,00027,072,00026,277,00026,417,00028,838,00022,341,000-23,113,00023,513,00025,402,00024,550,00019,894,0006,055,0005,127,0005,258,0004,932,0004,627,0004,338,000
Operating Expenses-53.8%43,056,00093,132,00041,175,00043,065,00037,117,00037,312,00034,220,00034,085,00030,160,000-31,475,50028,089,00029,150,00025,692,00029,739,50016,788,00010,973,0008,844,0005,810,95916,978,8076,642,787
  S&GA Expenses-1.3%38,304,00038,814,00036,023,00038,802,00033,241,00032,635,00030,235,00030,563,00026,622,000-27,586,00023,901,00024,688,00021,388,00026,247,00014,476,0009,026,0007,111,00020,073,3425,961,5932,843,073
  R&D Expenses0.1%4,752,0004,749,0005,152,0004,263,0003,876,0004,677,0003,985,0003,522,0003,538,000-3,889,5004,188,0004,462,0004,304,0003,492,5002,312,0001,947,0001,733,0001,069,9431,640,528540,933
EBITDA Margin-23.5%-0.35-0.28-0.05-0.020.01-0.03-1.11-1.13-1.13-1.10-1.120.01---------
Interest Expenses2.5%1,338,0001,306,0001,357,0001,331,0001,509,0001,456,0001,609,0001,586,0001,491,000-1,126,0001,189,0001,164,0001,210,000270,5001,889,000398,0002,000445,952248,410333,910
Income Taxes115.8%215,000-1,359,000471,000635,000492,0001,477,00057,000364,000341,000--875,5001,024,000499,0001,038,000-99,000-29,00050,00033,00051,3901,8869,624
Earnings Before Taxes70.7%-18,680,000-63,748,000-12,798,000-17,720,000-5,082,000-7,959,000-5,259,000-8,813,000-13,063,000--260,961,500-5,502,000-4,890,000-2,489,000-11,628,500-11,447,000-5,753,000-3,909,000-896,670-12,466,661-2,518,867
EBT Margin-17.8%-0.50-0.43-0.18-0.15-0.11-0.15-1.23-1.25-1.24-1.21-1.23-0.11---------
Net Income69.7%-18,895,000-62,389,000-13,269,000-18,355,000-5,574,000-11,436,000-5,316,000-9,177,000-13,404,000--262,086,000-8,526,000-7,389,000-5,723,000-53,866,000-11,418,000-5,803,000-3,943,000-948,000-12,469,000-2,528,000
Net Income Margin-17.5%-0.50-0.43-0.21-0.17-0.13-0.17-1.24-1.27-1.28-1.26-1.27-0.35---------
Free Cashflow20.0%-7,271,000-9,091,000-10,928,000-12,728,000-6,795,000-4,203,000-4,208,000-11,826,000-3,721,000-5,712,000-5,712,00025,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-1.6%9439581,0011,0311,0481,0391,0341,0461,0811,11382482582055225225314013613513360.00
  Current Assets-1.8%52653554958560560460962666669441041242014721321710510310210252.00
    Cash Equivalents7.2%50.0046.0059.0067.0039.0037.0031.0037.0013413944.0060.0085.0037.0016244.0051.0047.0045.0081.0033.00
  Inventory-4.5%25.0026.0029.0029.0026.0028.0025.0023.0022.0017.0013.0012.0012.0011.000.001.000.000.000.000.000.00
  Net PPE1.4%86.0085.0075.0069.0071.0064.0058.0054.0051.0049.0043.0038.0032.0030.0015.0014.0012.0012.0011.0010.005.00
  Goodwill-0.8%10810814914915215115114514714724.003.0014114510611.0011.0011.0011.0011.00-
Liabilities0.4%47146946348648848347847847247117717717217013212613.0010.0025.0024.0021.00
  Current Liabilities7.4%49.0046.0045.0040.0042.0041.0041.0044.0044.0043.0041.0038.0038.0035.0013.009.007.005.006.006.005.00
  Long Term Debt0.2%379379378408407407406405405404112112112111111111--15.0015.0015.00
    LT Debt, Non Current0.2%379379378408407407406405405404112112112111111111--15.0015.0015.00
Shareholder's Equity-3.4%47248953854456155655656860964264764864738312012712712611010939.00
  Retained Earnings-2.9%-661-642-580-566-548-542-503-498-489-467-207-200-195-192-180-169-163-159-158-145-143
  Additional Paid-In Capital0.4%1,1351,1311,1271,1231,1181,1151,0861,0821,1031,100846842838566300295290286269255182
Shares Outstanding0.6%49.0049.0049.0049.0048.0048.0049.0049.0050.0046.0046.0045.00---------
Float----500---1,100-------2.00-----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-231.5%-3,2652,482-1,959-4,0542,7743,654982-7,0115242,6148,8762,627-5,991-9,712-4,844-1,3691,059741-813-1,061-189
  Share Based Compensation-6.7%5,4565,8485,9765,8005,1845,3335,3665,2584,1254,1824,1484,0252,9902,5612,4332,3021,6201,6111,9461,9921,414
Cashflow From Investing143.7%6,445-14,76018,51033,678-1,3837,124-5,865-63,9903,050-195,971-27,008-30,905-215,370-383,060120,338-119,048-542790-36,645-21,419-5,651
Cashflow From Financing506.3%512-126-24,8911,14871.00-5,306-459-25,360-8,049288,5752,4911,883271,393266,4432,151114,1272,8641,0931,41070,3571,290
  Buy Backs------4,611-25,0008,349------------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

CYRX Income Statement

2024-03-31
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total revenue$ 54,592$ 62,817
Total cost of revenue32,81735,745
Gross margin21,77527,072
Operating costs and expenses:  
Selling, general and administrative38,30433,241
Engineering and development4,7523,876
Total operating costs and expenses43,05637,117
Loss from operations(21,281)(10,045)
Other income (expense):  
Investment income2,6002,467
Interest expense(1,338)(1,509)
Other income, net1,3394,005
Total other income, net2,6014,963
Loss before provision for income taxes(18,680)(5,082)
Provision for income taxes(215)(492)
Net loss(18,895)(5,574)
Paid-in-kind dividend on Series C convertible preferred stock(2,000)(2,000)
Net loss attributable to common stockholders$ (20,895)$ (7,574)
Net loss per share - basic (in dollar per share)$ (0.43)$ (0.16)
Net loss per share - diluted (in dollar per share)$ (0.43)$ (0.16)
Weighted average shares outstanding - basic (in shares)49,019,96448,362,501
Weighted average shares outstanding - diluted (in shares)49,019,96448,362,501
Life Sciences Services  
Total revenue$ 36,786$ 35,836
Total cost of revenue21,60219,076
Life Sciences Products  
Total revenue17,80626,981
Total cost of revenue$ 11,215$ 16,669

CYRX Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets:  
Cash and cash equivalents$ 49,663$ 46,346
Short-term investments398,881410,409
Accounts receivable, net41,25342,074
Inventories25,02026,206
Prepaid expenses and other current assets10,88710,077
Total current assets525,704535,112
Property and equipment, net86,00884,858
Operating lease right-of-use assets31,02932,653
Intangible assets, net190,088194,382
Goodwill107,588108,403
Deposits1,6741,680
Deferred tax assets758656
Total assets942,849957,744
Current Liabilities:  
Accounts payable and other accrued expenses27,37626,995
Accrued compensation and related expenses14,06211,409
Deferred revenue1,7771,308
Current portion of operating lease liabilities5,3565,371
Current portion of finance lease liabilities301286
Current portion of notes payable110149
Current portion of contingent consideration 92
Total current liabilities48,98245,610
Convertible senior notes, net of discount of $6.4 million and $7.0 million, respectively379,153378,553
Notes payable1,3051,335
Operating lease liabilities, net of current portion27,79829,355
Finance lease liabilities, net of current portion916954
Deferred tax liabilities2,4142,816
Other long-term liabilities312601
Contingent consideration, net of current portion9,7799,497
Total liabilities470,659468,721
Commitments and contingencies
Stockholders' Equity:  
Preferred stock, $0.001 par value; 2,500,000 shares authorized:
Common stock, $0.001 par value; 100,000,000 shares authorized; 49,256,794 and 48,971,026 issued and outstanding at March 31, 2024 and December 31, 2023, respectively4949
Additional paid-in capital1,135,2571,131,183
Accumulated deficit(661,314)(642,419)
Accumulated other comprehensive loss(30,077)(26,065)
Total stockholders' equity472,190489,023
Total liabilities and stockholders' equity942,849957,744
Class A convertible preferred stock  
Stockholders' Equity:  
Preferred stock, $0.001 par value; 2,500,000 shares authorized:
Class B convertible preferred stock  
Stockholders' Equity:  
Preferred stock, $0.001 par value; 2,500,000 shares authorized:
Class C convertible preferred stock  
Stockholders' Equity:  
Preferred stock, $0.001 par value; 2,500,000 shares authorized:$ 28,275$ 26,275
CYRX
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments: Global Logistics Solutions and Global Bioservices. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
 CEO
 WEBSITEcryoport.com
 INDUSTRYIntegrated Freight & Logistics
 EMPLOYEES1000

CryoPort Inc Frequently Asked Questions


What is the ticker symbol for CryoPort Inc? What does CYRX stand for in stocks?

CYRX is the stock ticker symbol of CryoPort Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CryoPort Inc (CYRX)?

As of Mon Jun 24 2024, market cap of CryoPort Inc is 388.64 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CYRX stock?

You can check CYRX's fair value in chart for subscribers.

What is the fair value of CYRX stock?

You can check CYRX's fair value in chart for subscribers. The fair value of CryoPort Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of CryoPort Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CYRX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is CryoPort Inc a good stock to buy?

The fair value guage provides a quick view whether CYRX is over valued or under valued. Whether CryoPort Inc is cheap or expensive depends on the assumptions which impact CryoPort Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CYRX.

What is CryoPort Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Jun 24 2024, CYRX's PE ratio (Price to Earnings) is -3.44 and Price to Sales (PS) ratio is 1.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CYRX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CryoPort Inc's stock?

In the past 10 years, CryoPort Inc has provided 0.445 (multiply by 100 for percentage) rate of return.